GDTC LongLooks like a decent trade with 2+ r/r, coming from a low base can go long after a period of accumulation
Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−0.27USD
−3.08 MUSD
3.96 M
About CytoMed Therapeutics Limited
Sector
Industry
CEO
Wee Kiat Tan
Website
Headquarters
Singapore
Employees (FY)
34
Founded
2018
ISIN
SGXZ17669631
FIGI
BBG01BM32FR8
CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GDTC is 2.10 USD — it has decreased by 4.55% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CytoMed Therapeutics Limited stocks are traded under the ticker GDTC.
CytoMed Therapeutics Limited is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
GDTC stock is 5.01% volatile and has beta coefficient of 1.18. Check out the list of the most volatile stocks — is CytoMed Therapeutics Limited there?
Yes, you can track CytoMed Therapeutics Limited financials in yearly and quarterly reports right on TradingView.
GDTC stock has fallen by 0.94% compared to the previous week, the month change is a 10.63% fall, over the last year CytoMed Therapeutics Limited has showed a 38.24% decrease.
GDTC net income for the last quarter is −1.46 M USD, while the quarter before that showed −1.61 M USD of net income which accounts for 9.41% change. Track more CytoMed Therapeutics Limited financial stats to get the full picture.
No, GDTC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GDTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CytoMed Therapeutics Limited stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 34.00 employees. See our rating of the largest employees — is CytoMed Therapeutics Limited on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CytoMed Therapeutics Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CytoMed Therapeutics Limited stock shows the strong sell signal. See more of CytoMed Therapeutics Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.